Cultured Mold Antifungal Drug Sensitivity Test (DST) in Dubai, UAE

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified processing (Cert: INT/EGQ/2509DA/3139).

Premium Logistics: Hospital extraction only – sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Secure medical courier retrieval of the cultured isolate.

Clinical Guidance: Telephonic post-test clinical guidance for result interpretation provided by a licensed physician.

Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Turnaround: Final report issued within 7 calendar days of isolate receipt.

Test Overview & Methodology

The Cultured Mold Antifungal Drug Sensitivity Test (DST) identifies the most effective antifungal agents against a patient's isolated mold pathogen, enabling precise, personalized treatment. This advanced microbroth dilution assay supports dermatologists, infectious disease specialists, and clinical microbiologists in managing resistant or invasive fungal infections within the UAE's regulatory framework.

Feature	Our Test (AMCA-Certified)	Closest Alternative
Precision	ISO-accredited microbroth dilution (CLSI M38-A3/M38-Ed3) with 99.9% sensitivity	Non-standardized broth/agar dilution – variable accuracy
Methodology	Quantitative MIC (minimum inhibitory concentration) against 9–12 antifungals	Qualitative disk diffusion – limited interpretive categories
Speed	Sample accepted daily by 9 AM; report in 7 days	Often 10–14 days without cold-chain logistics
Regulatory	DHA/MOHAP compliant, ISO 9001:2015, UAE PDPL data privacy	May lack local regulatory approval

Physician Insight & Safety Protocols

Insight from Dr. Ajay Singh (DHA Registration ID: 36234132) – General Practitioner

"A cultured mold antifungal DST is an invaluable tool for patients failing first-line therapy; however, it must always be interpreted alongside the patient's clinical condition and immune status. Result-guided adjustments should only be made by the treating physician after a comprehensive evaluation of the patient's history and current presentation."

⚠ Medication Safety Advisory

Do not discontinue prescribed medication without consulting your doctor.

This test guides therapy but is not a substitute for medical oversight. Results must be reviewed alongside clinical history, radiology, and previous laboratory findings. Self-adjusting antifungal medications may lead to treatment failure or adverse events.

Exclusion Criteria & Emergency Red Flags

Exclusion: Patients with unstable invasive fungal sepsis; inability to provide a pure mold isolate; minors without parental or guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Red Flags (seek emergency care immediately): Sudden high fever with chills, hypotension, rapidly spreading skin necrosis, or symptoms suggestive of disseminated fungal infection.

Patient FAQ & Clinical Guidance

1. How reliable is this mold DST test for guiding my antifungal therapy?

This ISO‑certified microbroth dilution assay delivers greater than 99% analytical accuracy for clinically relevant antifungal susceptibility profiles, guiding tailored treatment in complex mold infections. The methodology (CLSI M38‑A3/Ed3) quantifies minimum inhibitory concentrations, helping your doctor choose the most effective drug. Results are interpreted alongside your clinical status and immune profile for a comprehensive treatment plan.

2. How is the mold sample collected and transported?

Specimen collection for mold culture must be performed in a hospital setting by qualified clinical staff. The cultured isolate is then retrieved by a secure medical courier under temperature-controlled conditions, ensuring sample stability throughout transit. This process complies with UAE health logistics standards and maintains the integrity of the fungal isolate for accurate susceptibility testing.

3. What should I do if my result shows resistance to all tested antifungals?

A pan‑resistant result immediately triggers a mandatory clinical consultation with your ordering physician to reassess therapy and explore newer antifungals or combination regimens. Never self‑adjust medication; your doctor may request additional susceptibility testing or refer you to an infectious disease specialist. Prompt medical follow-up is critical when resistance is detected.

UAE Regulatory & Data Privacy Adherence

Your data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical records and test results are encrypted, access-controlled, and processed in compliance with Dubai Healthcare City Authority regulations. DNA Labs UAE maintains strict confidentiality and transparency in every stage of laboratory testing and result delivery.

Clinical & Logistical Metadata

Test Name	Cultured Mold Antifungal Drug Sensitivity Test (DST)
Price (AED)	1,900
Turnaround Time	7 calendar days from isolate receipt
Sample Type / Matrix	Fungal culture isolate (mold colony) – Hospital extraction only. Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Methodology Used	Quantitative microbroth dilution per CLSI M38-A3/Ed3 (MIC determination against antifungal panel)
ICD-10-CM Code	B48.8 (Other specified mycoses)
LOINC Code	100329-9 (Fungal susceptibility panel)
DHA Facility License & Address	License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE